Winship Logo

Emory Glenn Family Breast Center Publications

December 20244 publications

AuthorsDate PublishedJournalTitle
Manali Bhave
12/10/2024Journal of clinical oncology : official journal of the American Society of Clinical OncologyImlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Phase Ia/Ib EMBER Study.
Curtis J Henry
12/01/2024LeukemiaMERTK inhibition selectively activates a DC - T-cell axis to provide anti-leukemia immunity.
Jane L Meisel
Kevin M Kalinsky
12/01/2024Nature medicineDatopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.
Kevin Kalinsky
12/01/2024Nature medicineDatopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.

November 20244 publications

AuthorsDate PublishedJournalTitle
Kevin Kalinsky
11/20/2024Journal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I/Ib Trial of Inavolisib Plus Palbociclib and Endocrine Therapy for <i>PIK3CA</i>-Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced or Metastatic Breast Cancer.
Gulisa Turashvili
Xiaoxian Li
11/19/2024Journal of clinical pathologyLow interobserver agreement among subspecialised breast pathologists in evaluating HER2-low breast cancer.
Kevin Kalinsky
Manali Ajay Bhave
11/01/2024Breast cancer research and treatmentReal-world use patterns, effectiveness, and tolerability of sacituzumab govitecan for second-line and later-line treatment of metastatic triple-negative breast cancer in the United States.
Manali Bhave
Jane L Meisel
Mylin A Torres
Toncred M Styblo
Cathy L Graham
Kevin Kalinsky
Jeffrey Switchenko
David M Schuster
11/01/2024European journal of nuclear medicine and molecular imagingProspective investigation of amino acid transport and PSMA-targeted positron emission tomography for metastatic lobular breast carcinoma.

October 20248 publications

AuthorsDate PublishedJournalTitle
Anant Madabhushi
10/01/2024Advances in radiation oncologyLaterality of Radiation Therapy in Breast Cancer is Not Associated With Increased Risk of Coronary Artery Disease in the Contemporary Era.
Lauren M Postlewait
Cletus A Arciero
10/01/2024Annals of surgical oncologyClipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial.
Cletus Arciero
Jade Jones
Lauren M Postlewait
10/01/2024Annals of surgical oncologyDefining the Need for Services for Patients at High Risk of Breast Cancer at a Safety-Net Hospital: An Approach to Narrowing the Disparities Gap.
Lauren Postlewait
10/01/2024Annals of surgical oncologyInternal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial.
Gulisa Turashvili
Sunil Shankar Badve
10/01/2024Archives of pathology & laboratory medicineIdentification of Glandular (Acinar)/Tubule Formation in Invasive Carcinoma of the Breast: A Study to Determine Concordance Using the World Health Organization Definition.
Manali A Bhave
Kevin Kalinsky
10/01/2024Breast cancer research and treatmentComprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice.
Xiaoxian Li
10/01/2024Cancer research communicationsTumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER- Breast Cancer.
Ilana Graetz
Jane Meisel
Keerthi Gogineni
Mylin A Torres
10/01/2024JCO oncology practiceLeveraging Mobile Health to Improve Capecitabine Adherence Among Women With Breast Cancer: A Pilot Randomized Controlled Trial.

September 202410 publications

AuthorsDate PublishedJournalTitle
Cathy Graham
09/27/2024BMC medical informatics and decision makingUse of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904).
Timothy L Lash
09/20/2024Breast cancer research and treatmentGenetic variants and social benefit receipt in premenopausal women with breast cancer treated with docetaxel: a Danish population-based cohort study.
Jane Meisel
09/20/2024Breast cancer research and treatmentGenomic and transcriptomic landscape of HER2-low breast cancer.
Reshma Jagsi
09/17/2024JCO oncology practiceFinancial Toxicity Screening Preferences in Patients With Breast Cancer.
Lauren E McCullough
09/15/2024International journal of cancerSecond primary cancer risks according to race and ethnicity among U.S. breast cancer survivors.
Kevin Kalinsky
09/12/2024Journal of clinical oncology : official journal of the American Society of Clinical OncologyDatopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Primary Results From TROPION-Breast01.
Mylin A Torres
09/11/2024BMJ (Clinical research ed.)Randomised controlled trials on radiation dose fractionation in breast cancer: systematic review and meta-analysis with emphasis on side effects and cosmesis.
Kevin C Ward
09/10/2024Journal of clinical oncology : official journal of the American Society of Clinical OncologyGenetic Counseling, Testing, and Family Communication Into Survivorship After Diagnosis of Breast Cancer.
Lauren M Postlewait
Xiaoxian Li
09/01/2024Breast cancer research and treatmentChanges in expression of breast cancer tumor biomarkers between primary tumors and corresponding metastatic sites: common patterns and relationships with survival.
Michael Goodman
Lauren E McCullough
Timothy L Lash
09/01/2024Epidemiology (Cambridge, Mass.)The Population-level Effect of Adjuvant Therapies on Breast Cancer Recurrence: Application of the Trend-in-Trend Design.

August 20246 publications

AuthorsDate PublishedJournalTitle
Jeffrey M Switchenko
Karen Godette
Monica Rizzo
08/29/2024Journal of surgical oncologyIntraoperative radiation therapy for early-stage breast cancer.
Kevin Kalinsky
08/01/2024EMBO molecular medicineFLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer.
Demetria J Smith-Graziani
Reshma Jagsi
08/01/2024International journal of radiation oncology, biology, physicsOut-of-Pocket Cost Modeling of Adjuvant Antiestrogen and Radiation Therapy After Lumpectomy for Early-Stage Breast Cancer Across Medicaid and Medicare Plans.
Sunil S Badve
08/01/2024JAMA oncologyTumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy.
Xiaoxian Li
08/01/2024Modern pathology : an official journal of the United States and Canadian Academy of Pathology, IncBreast Cancer With HER2 Immunohistochemical Score 2 and Average HER2 Signals/Cell 6 or More and HER2/CEP17 Ratio Less Than 2 ('ISH Group 3'): A Multi-Institutional Cohort Analysis Emphasizing Outcome and Molecular Subtype.
Sunil S Badve
08/01/2024NEJM evidenceClinical and Genomic Risk for Late Breast Cancer Recurrence and Survival.

July 20246 publications

AuthorsDate PublishedJournalTitle
Ritu Aneja
07/29/2024Clinical proteomicsQuantitative proteomics reveals serum proteome alterations during metastatic disease progression in breast cancer patients.
Kevin M Kalinsky
07/26/2024JCO oncology practiceUse of a Smartphone Application to Promote Adherence to Oral Medications in Patients With Breast Cancer.
Jane Meisel
07/19/2024JCO oncology practiceSubcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial).
Reshma Jagsi
07/15/2024International journal of radiation oncology, biology, physicsAre We Missing Acute Toxicities Associated With Hypofractionated Breast Irradiation? A Report From a Large Multicenter Cohort Study.
C Graham
07/01/2024Contemporary clinical trialsMaking Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial.
Kevin Kalinsky
07/01/2024JCO oncology practiceThe Right Dose: Results of a Patient Advocate-Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Related Side Effects and Views About Dosage Assessment to Optimize Quality of Life.

June 20246 publications

AuthorsDate PublishedJournalTitle
Jane Meisel
06/10/2024Journal of clinical oncology : official journal of the American Society of Clinical OncologyPACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer.
Joellen Schildkraut
06/06/2024American journal of human geneticsCis- and trans-eQTL TWASs of breast and ovarian cancer identify more than 100 susceptibility genes in the BCAC and OCAC consortia.
Jeffrey M Switchenko
Kevin C Ward
Lauren E McCullough
06/03/2024JAMA network openNeighborhood Deprivation and Breast Cancer Mortality Among Black and White Women.
Ilana Graetz
06/03/2024JAMA network openRemote Monitoring App for Endocrine Therapy Adherence Among Patients With Early-Stage Breast Cancer: A Randomized Clinical Trial.
Jade Jones
Jeffrey M Switchenko
Kevin C Ward
Lauren E McCullough
06/01/2024Breast cancer research and treatmentRacial disparities in initiation of chemotherapy among breast cancer patients with discretionary treatment indication in the state of Georgia.
Jinbing Bai
06/01/2024European journal of oncology nursing : the official journal of European Oncology Nursing SocietyThe impact of fear of cancer recurrence on the quality of life of breast cancer patients: A longitudinal study of the mediation effect of cortisol and hope.

May 20243 publications

AuthorsDate PublishedJournalTitle
Kevin Kalinsky
05/20/2024Journal of clinical oncology : official journal of the American Society of Clinical OncologyFinal Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression.
Ramireddy Bommireddy
Adam Marcus
Periasamy Selvaraj
05/15/2024International journal of molecular sciencesTumor-Intrinsic Enhancer of Zeste Homolog 2 Controls Immune Cell Infiltration, Tumor Growth, and Lung Metastasis in a Triple-Negative Breast Cancer Model.
Jane L Meisel
Xiaoxian Li
05/01/2024Breast cancer research and treatmentHigh tumor infiltrating lymphocytes are significantly associated with pathological complete response in triple negative breast cancer treated with neoadjuvant KEYNOTE-522 chemoimmunotherapy.

April 20243 publications

AuthorsDate PublishedJournalTitle
Kevin Kalinsky
04/25/2024NPJ breast cancerSubgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer.
Timothy L Lash
04/08/2024Breast cancer research : BCRClinical factors associated with patterns of endocrine therapy adherence in premenopausal breast cancer patients.
Gulisa Turashvili
Xiaoxian Li
04/01/2024Breast cancer research and treatmentSubspecialized breast pathologists have suboptimal interobserver agreement in Ki-67 evaluation using 20% as the cutoff.